Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.
LivaNova PLC (NASDAQ:LIVN) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 19, 2026, LivaNova PLC ...
The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...
A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.
LIVN wins FDA nod for its aura6000 sleep apnea system, marking a pivotal step in neurostimulation with strong trial results ...
Sleep apnea breakthrough: Clinical trial finds drug sulthiame may reduce night-time breathing pauses
Obstructive sleep apnea occurs when the upper airway repeatedly collapses during sleep, temporarily blocking airflow ...
Obstructive sleep apnea was common in never-smokers with lung cancer. Read more about the prospective findings.
Add Yahoo as a preferred source to see more of our stories on Google. Complications of OSA include unstable oxygen Obstructive sleep apnea (OSA) is a condition in which airflow is blocked during sleep ...
Dear Savvy Senior: I’ve been diagnosed with sleep apnea and have been trying to use a CPAP device for the past six months but can’t tolerate it. Are there any alternative treatment options? — Sleepy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results